Shopping Cart
- Remove All
- Your shopping cart is currently empty
DL-TBOA is an inhibitor of excitatory amino acid transporter proteins, inhibiting excitatory amino acid transporter protein 1 (EAAT1), EAAT2, and EAAT3.
Description | DL-TBOA is an inhibitor of excitatory amino acid transporter proteins, inhibiting excitatory amino acid transporter protein 1 (EAAT1), EAAT2, and EAAT3. |
Targets&IC50 | EAAT2:6 μM, EAAT2 (human):5.7 μM, EAAT5:3.2 μM, EAAT1:70 μM, EAAT1 (human):42 μM (Ki), EAAT4:4.4 μM, EAAT3:6 μM |
In vitro | In HCT116 and LoVo cell lines, DL-TBOA (70 μM, 350 μM; 48 hours) enhances SN38-induced cell death and counteracts Oxaliplatin-induced cell death[4]. |
In vivo | In male Sprague-Dawley rats (180-250 g), DL-TBOA (1 nmol, 3 nmol, 10 nmol;i.c.v.) dose-dependently facilitated various somatic signs induced by Naloxone (0.1 mg/kg)[5]. |
Alias | DLTBOA, DL TBOA |
Molecular Weight | 239.22 |
Formula | C11H13NO5 |
Cas No. | 205309-81-5 |
Smiles | [C@@H]([C@@H](C(O)=O)N)(OCC1=CC=CC=C1)C(O)=O |
Relative Density. | 1.392 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 2 mg/mL (8.36 mM), Sonication is recommended. DMSO: 100 mg/mL (418.00 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.